Sucralfate suppresses Helicobacter pylori infection and reduces gastric acid secretion by 50% in patients with duodenal ulcer.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Gastroenterology

• Publication date

  1996-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/GAST.1996.V110.PM8608880PMID 8608880
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease.

  1995cited by this paper
• Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer.

  1993cited by this paper
• Is there a place for antacids in the treatment of Helicobacter pylori infection?

  1992cited by this paper
• Role of ammonia in the pathogenesis of the gastritis, hypergastrinaemia, and hyperpepsinogenaemia I caused by Helicobacter pylori infection.

  1992cited by this paper
• Enhancement of gastric mucosal epidermal growth factor and platelet-derived growth factor receptor expression by sucralfate.

  1992cited by this paper
• Effect of sucralfate on gastric mucosal calcium channels activity.

  1992cited by this paper
• Sucralfate diminishes basal acid output without affecting gastrin, H. pylori or gastritis in duodenal ulcer patients

  1992cited by this paper
• Effect of sucralfate on the degradation of human gastric mucus by Helicobacter pylori protease and lipases.

  1992cited by this paper
• Sucrose octasulfate stimulates gastric somatostatin release.

  1991cited by this paper
• Enhancement of the protective qualities of gastric mucus by sucralfate: role of phosphoinositides.

  1991cited by this paper
• Inhibition of gastric mucosal laminin receptor by Helicobacter pylori lipopolysaccharide: effect of sucralfate.

  1991cited by this paper
• Acid secretory responses and parietal cell sensitivity following duodenal ulcer healing with omeprazole, sucralfate, and Maalox.

  1991cited by this paper
• Acid secretory changes and early relapse following duodenal ulcer healing with ranitidine or sucralfate.

  1991cited by this paper
• Duodenal ulcer healing and acid secretory responses to modified sham feeding and pentagastrin stimulation

  1990cited by this paper
• Effect of bismuth subcitrate and sucralfate on rat duodenal and human gastric bicarbonate secretion in vivo.

  1990cited by this paper
• Suppression of gastric urease activity by antacids.

  1990cited by this paper
• Epidermal growth factor in the gastroprotective and ulcer-healing actions of sucralfate in rats.

  1989cited by this paper
• Acid-secretory response and parietal cell sensitivity in patients with duodenal ulcer before and after treatment with sucralfate or ranitidine.

  1989cited by this paper
• Sucralfate and ranitidine in the treatment of acute duodenal ulcer. Healing and relapse. Ulcer Study Group.

  1989cited by this paper
• Comparison of relapse rates and of mucosal abnormalities after healing of duodenal ulceration and after one year's maintenance with cimetidine or sucralfate: a light and electron microscopy study.

  1989cited by this paper
• Comparison of sucralfate and ranitidine in the treatment of chronic nonerosive gastritis. A randomized, multicenter trial.

  1989cited by this paper
• Effect of sucralfate on gastric mucosal blood flow in rats.

  1989cited by this paper
• Na+/H+ ion-exchange property of postmortem human gastric mucus. The effects of Campylobacter pylori infection and sucralfate.

  1989cited by this paper
• Sucralfate interactions with gastric mucus.

  1989cited by this paper
• Implications of sucralfate-induced ulcer healing and relapse.

  1989cited by this paper
• Campylobacter pylori colonization factor shows specificity for lactosylceramide sulfate and GM3 ganglioside.

  1989cited by this paper
• Effect of sucralfate and cimetidine on duodenal ulcer-associated antral gastritis and Campylobacter pylori.

  1989cited by this paper
• Antacids reduce Campylobacter pylori colonization without healing the gastritis in patients with nonulcer dyspepsia and erosive prepyloric changes.

  1988cited by this paper
• Stimulation of amphibian gastroduodenal bicarbonate secretion by sucralfate and aluminium: role of local prostaglandin metabolism.

  1988cited by this paper
• Effects of sucralfate on gastric prostaglandin and leukotriene synthesis: relationship to protective actions.

  1988cited by this paper
• Site-protective agents.

  1988cited by this paper
• Does epidermal growth factor play a role in the action of sucralfate?

  1987cited by this paper
• Antibacterial activity of sucralfate in human gastric juice.

  1987cited by this paper
• Cresyl fast violet staining method for Campylobacter like organisms.

  1987cited by this paper
• Effects of sucralfate on gastroduodenal bicarbonate secretion and prostaglandin E2 metabolism.

  1987cited by this paper
• Prevention of Ethanol-Induced Vascular Injury and Gastric Mucosal Lesions by Sucralfate and Its Components: Possible Role of Endogenous Sulfhydryls

  1987cited by this paper
• Effect of sucralfate on the viscosity of gastric mucus and the permeability to hydrogen ion.

  1986cited by this paper
• Sucralfate Compared with Ranitidine in the Short-Term Healing of Duodenal Ulcers

  1985cited by this paper
• Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents

  1985cited by this paper
• Inhibition of peptic activity by sucralfate.

  1985cited by this paper
• In vitro adsorption of bile salts and aspirin to sucralfate

  1984cited by this paper
• Inhibition of peptic aggression by sucralfate. The view from the ulcer crater.

  1983cited by this paper
• Inhibition of peptic aggression by sucralfate. The view from the ulcer crater.

  1983cited by this paper
• Relapse rates after initial ulcer healing with sucralfate and cimetidine.

  1982cited by this paper
• Selective binding of sucralfate to gastric ulcer in man

  1981cited by this paper

• Anti-Gastric Ulcer Activity of Aqueous Extract of Terminalia Arjuna Against Helicobacter Pylori Lipopolysaccharide

  2018cites this paper
• Gr upSM Drug Treatment of Peptic Ulcer Disease

  2016cites this paper
• Aegle marmelos fruit extract attenuates Helicobacter pylori Lipopolysaccharide induced oxidative stress in Sprague Dawley rats

  2015cites this paper
• Lactobacillus reuteri Strain Combination In Helicobacter pylori Infection: A Randomized, Double-Blind, Placebo-Controlled Study

  2013cites this paper
• Bacterial Load and Degree of Gastric Mucosal Inflammation in Helicobacter pylori Infection

  2011cites this paper
• The functions and roles of the extracellular Ca2+-sensing receptor along the gastrointestinal tract.

  2009cites this paper
• Gastrointestinal Disease in Pregnancy

  2009cites this paper
• Effect of methanolic extract of Terminalia arjuna against Helicobacter pylori 26695 lipopolysaccharide‐induced gastric ulcer in rats

  2008cites this paper
• Gastric mucosal inflammatory responses toHelicobacter pylori lipopolysaccharide: Suppression of caspase-3 and nitric oxide synthase-2 by omeprazole and sucralfate

  2008cites this paper
• Role of calcium and other trace elements in the gastrointestinal physiology.

  2006cites this paper
• Effects of acute and chronic restraint stress on visceral sensitivity and neuroendocrine hormones in rats.

  2006cites this paper
• Functions and roles of the extracellular Ca2+-sensing receptor in the gastrointestinal tract.

  2004cites this paper
• The Effectiveness of Sucralfate Against Stricture Formation in Experimental Corrosive Esophageal Burns

  2004cites this paper
• Effect of Sucralfate on Antibiotic Therapy for Helicobacter pylori Infection in Mice

  2004cites this paper
• Altered visceral perceptual and neuroendocrine response in patients with irritable bowel syndrome during mental stress

  2004cites this paper
• Teprenone, but not H2‐Receptor Blocker or Sucralfate, Suppresses Corpus Helicobacter pylori Colonization and Gastritis in Humans: Teprenone Inhibition of H. pylori‐Induced Interleukin‐8 in MKN28 Gastric Epithelial Cell Lines

  2004cites this paper
• Irritable Bowel Syndrome Patients Show Enhanced Modulation of Visceral Perception by Auditory Stress

  2003cites this paper
• Gastric and duodenal ulcers during pregnancy.

  2003cites this paper
• Influence of anti-ulcer drugs used in Japan on the result of 13C-urea breath test for the diagnosis of Helicobacter pylori infection

  2003cites this paper
• Peptic ulcer disease.

  2002cites this paper
• Role of visceral sensitivity in the pathophysiology of irritable bowel syndrome

  2002cites this paper
• Gastrin‐releasing peptide is a potent vasodilator in humans

  2001cites this paper
• Gastric acid secretory response in Helicobacter pylori-positive patients with duodenal ulcer disease.

  2001influential citation
• Amoxycillin, clarithromycin and either sucralfate or pantoprazole for eradication of Helicobacter pylori in duodenal ulcer (a randomized controlled trial).

  2001cites this paper
• Prolonged Storage of Frozen Unbuffered Rapid Urease Test

  2000influential citation
• Role of tachykinin NK2 receptors in normal and altered rectal sensitivity in rats

  2000cites this paper
• Efficacy of sucralfate for Helicobacter pylori eradication triple therapy in comparison with a lansoprazole‐based regimen

  2000cites this paper
• Ethanol intake preceding Helicobacter pylori inoculation promotes gastric mucosal inflammation in Mongolian gerbils

  1999cites this paper
• The CLO test in the UK: inappropriate reading and missed results.

  1999cites this paper
• Injurious effect of Helicobacter pylori culture fluid to gastroduodenal mucosa, and its detoxification by sucralfate in the rat

  1999cites this paper
• Effect of sucralfate on gastric mucosal inflammatory responses induced by Helicobacter pylori lipopolysaccharide.

  1998cites this paper
• Gastric and duodenal ulcers during pregnancy.

  1998cites this paper
• Interactions between H. pylori infection, gastric acid secretion and anti-secretory therapy.

  1998cites this paper
• La réaction de la polymérase en chaîne constitue un important apport dans le diagnostic et le suivi des lymphomes gastriques

  1998cites this paper
• The eradication treatments of Helicobacter pylori.

  1998cites this paper
• A novel Alcian yellow-toluidine blue (Leung) stain for Helicobacter species: comparison with standard stains, a cost-effectiveness analysis, and supplemental utilities.

  1998cites this paper
• Effect of simethicone on the accuracy of the rapid urease test

  1998cites this paper
• Effect of Chronic Duodenal Ulceration and Its Treatment with Lanzoprazole or Sucralfate on Gastroduodenal Mucosal Protein Turnover and TGF-α, bFGF, and EGF Receptor Expression in Humans

  1998cites this paper
• Incidence of duodenal ulcer healing after 1 week of proton pump inhibitor triple therapy for eradication of Helicobacter pylori

  1998cites this paper
• Basal and pentagastrin stimulated acid secretion in duodenal ulcer subjects before and after Helicobacter pylori eradication: a 12-month follow-up study.

  1998cites this paper
• Eradicating Helicobacter pylori reduces hypergastrinaemia during long term omeprazole treatment

  1998cites this paper
• Incidence of duodenal ulcer healing after 1 week of proton pump inhibitor triple therapy for eradication of Helicobacter pylori

  1998cites this paper
• Pharmacologic management of common gastrointestinal health problems in women.

  1997cites this paper
• The gastric lymphomas and the role of Helicobacter pylori in tumour development: have criteria been set for diagnosis?

  1996cites this paper
• Leading Article: Leading Article Anti-infectives: Prospects for improved therapy for Helicobacter pylori infection

  1996cites this paper
• Sucralfate and Helicobacter pylori.

  1996cites this paper
• Helicobacter pylori and gastroduodenal secretory function.

  1996cites this paper